Widening for clopidogrel BE study [Outliers]

posted by mittyri – Russia, 2021-06-16 16:04 (173 d 00:57 ago) – Posting: # 22419
Views: 1,314

Dear Loky do

» is widening of Cmax accepted in clopidogrel BE studies with fully replicate design or not?

You linked the EMA Q&A where it is stated unequivocally:
Under these circumstances, the widening of 90% confidence intervals for Cmax is not recommended.

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,788 posts in 4,557 threads, 1,548 registered users;
online 14 (2 registered, 12 guests [including 6 identified bots]).
Forum time: Monday 16:01 CET (Europe/Vienna)

The history of statistics is like a telephone directory:
the plot is boring, full of numbers and the cast is endless.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5